NRYX Labs

Research Confirmation

All products are sold for Research Use Only. They are not drugs, foods, supplements, or cosmetics, are not approved by the FDA, and are not intended to diagnose, treat, cure, or prevent any disease, or for human or veterinary consumption. To continue you confirm that you are a qualified research professional aged 21 or older.

COA Per Lot◆Same-Day Ship by 2PM EST◆USA Sourced · USA Shipped◆Free Shipping over $300◆≥99% Purity · HPLC + MS◆Lot-Traceable Inventory◆COA Per Lot◆Same-Day Ship by 2PM EST◆USA Sourced · USA Shipped◆Free Shipping over $300◆≥99% Purity · HPLC + MS◆Lot-Traceable Inventory◆
For Laboratory & Research Use Only — Not for Human or Veterinary Use

NRYX-RETA30

RETATRUTIDE 30MG (RETA)

Retatrutide is a synthetic peptide engineered to interact with multiple metabolic receptor systems including GLP-1, GIP, and glucagon receptors. In laboratory studies, this compound is utilized for examining receptor binding dynamics and endocrine pathway signaling.

RETATRUTIDE 30MG (RETA) — research reagent
$100.00
In Stock
1

Research Use Only

For laboratory and in-vitro research purposes only. Not for human consumption, diagnosis, or treatment. Not for in-vivo use.

About RETATRUTIDE 30MG (RETA)

RETATRUTIDE 30MG (RETA) Reference Standard

The RETATRUTIDE 30MG (RETA) reagent, SKU NRYX-RETA30, is a specialized synthetic peptide engineered for precise application in high-level laboratory research. With a certified purity of 99.9%, this compound serves as an essential analytical standard for researchers investigating complex receptor binding dynamics and endocrine signaling pathways. By providing a stable, high-purity reference material, NRYX Labs supports the standardization of analytical protocols required for rigorous, data-driven in-vitro experimentation.

In the context of assay development and quality control, Retatrutide offers a controlled medium for assessing the interaction kinetics of GLP-1, GIP, and glucagon receptor systems. Its utility is grounded in its consistent molecular composition, allowing laboratories to conduct reproducible investigations into multi-receptor signaling mechanisms. This reagent is provided in a stable format, facilitating its integration into diverse analytical workflows that demand high technical accuracy and material reliability for valid comparative studies.

For optimal preservation of the compound's integrity, this reagent must be stored according to rigorous laboratory protocols to ensure the longevity of its chemical properties. Scientists and quality control technicians utilizing the RETATRUTIDE 30MG standard rely on its documented purity to maintain the standard of their experimental environments. Whether utilized for benchmarking new assay platforms or verifying existing methodology, this reagent serves as a fundamental component in the systematic study of metabolic receptor signaling in vitro.

Research Use Only

This product is strictly for laboratory and in-vitro research use only. It is not intended for human consumption, clinical use, or for the diagnosis, prevention, mitigation, or treatment of any medical condition or disease. Handle only in a professional laboratory environment by qualified personnel.

Product Specifications

SKU

NRYX-RETA30

Purity

99.9

Storage & Handling

Refer to the product's Certificate of Analysis and Safety Data Sheet for verified storage and handling guidance. Handle using appropriate personal protective equipment and good laboratory practice. Integrity is best maintained when the reagent is stored as directed and protected from moisture, light, and repeated temperature cycling.

Shipping & Ordering

Orders received by 2:00 PM EST ship same business day, subject to verification. Flat-rate shipping is $9.99, and orders of $300 or more ship free. A tracking number and carrier confirmation are provided when your order is marked shipped.

Research Use Only

RETATRUTIDE 30MG (RETA) is sold exclusively for laboratory and in-vitro research purposes. It is not intended for human consumption, diagnosis, treatment, or mitigation of any disease, and is not for in-vivo use. NRYX Labs makes no medical, therapeutic, weight-loss, or human-use claims. Researchers are responsible for determining suitability for their specific applications.

Related Research Products

Research & Resources